Environmental Policy

EPAX’s business is based on processing natural resources from the sea, and it has specialised in the production of concentrated omega-3 from fatty fish. The company is entirely dependent on marine resources being managed in a sustainable manner, and on the oceans remaining clean and free from waste products. EPAX will therefore endeavour to buy from businesses that are subject to regulatory control regimes and focus on the environment and sustainability.

All by-products and waste from the company’s activities must be properly disposed of. EPAX defines waste as a resource, and it will endeavour to find means of reusing such products.

EPAX will reduce its emissions of greenhouse gases through the optimisation of transport in connection with the company’s business and, as far as possible, choose the most environmentally friendly means of transport.

Energy conservation should be a central part of all projects in EPAX, and it is important that the company's growth does not result in corresponding growth in energy consumption.

EPAX must be conscious and aware of the impact of its operations on neighbours and nearby communities.

As a minimum, the company’s day-to-day operations will comply with regulations and requirements to which the company is subject.

EPAX will implement an environmental policy aimed at ensuring continued environmental improvement and the prevention of pollution.

 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map        Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com